Volume 30; Issue 5

Main
Anti-Cancer Drugs
Volume 30; Issue 5

Anti-Cancer Drugs

Volume 30; Issue 5

1

Talazoparib has no clinically relevant effect on QTc interval in patients with advanced solid tumors

Hoffman, Justin, Chakrabarti, Jayeta, Plotka, Anna, Milillo Naraine, Adriana, Kanamori, David, Moroose, Rebecca, Nguyen, Linh, Wang, Diane, Wainberg, Zev A.

Journal:

Anti-Cancer Drugs

Year:

2019

Language:

english

File:

PDF, 251 KB

english, 2019

2

A systematic review of preventive and therapeutic options for symptoms of cystitis in patients with bladder cancer receiving intravesical bacillus Calmette–Guérin immunotherapy

Poletajew, Sławomir, Krajewski, Wojciech, Adamowicz, Jan, Radziszewski, Piotr

Journal:

Anti-Cancer Drugs

Year:

2019

File:

PDF, 361 KB

2019

3

Increased SPK1 expression promotes cell growth by activating the ERK1/2 signaling in non-small-cell lung cancer

Yang, Yang, Zhao, Jie, Hao, Dong, Wang, Xiaozhi, Wang, Tao, Li, Hongbo, Lv, Bingjie

Journal:

Anti-Cancer Drugs

Year:

2019

File:

PDF, 413 KB

2019

4

Sinensetin induces apoptosis and autophagy in the treatment of human T-cell lymphoma

Tan, Kok-Tong, Lin, Meng-Xian, Lin, Shih-Chao, Tung, Yu-Tang, Lin, Sheng-Hao, Lin, Chi-Chien

Journal:

Anti-Cancer Drugs

Year:

2019

File:

PDF, 516 KB

2019

5

Talazoparib has no clinically relevant effect on QTc interval in patients with advanced solid tumors

Hoffman, Justin, Chakrabarti, Jayeta, Plotka, Anna, Milillo Naraine, Adriana, Kanamori, David, Moroose, Rebecca, Nguyen, Linh, Wang, Diane, Wainberg, Zev A.

Journal:

Anti-Cancer Drugs

Year:

2019

File:

PDF, 251 KB

2019

6

Ethyl-2-amino-pyrrole-3-carboxylates are active against imatinib-resistant gastrointestinal stromal tumors in vitro and in vivo

Boichuk, Sergei, Galembikova, Aigul, Dunaev, Pavel, Micheeva, Ekaterina, Novikova, Maria, Khromova, Natalya, Kopnin, Pavel

Journal:

Anti-Cancer Drugs

Year:

2019

File:

PDF, 780 KB

2019

7

Fluvastatin exerts an antitumor effect in vemurafenib-resistant melanoma cells

Nishiya, Masao, Yasuhira, Shinji, Shibazaki, Masahiko, Oikawa, Hiroki, Masuda, Tomoyuki, Maesawa, Chihaya

Journal:

Anti-Cancer Drugs

Year:

2019

File:

PDF, 304 KB

2019

8

Liver X receptor agonist T0901317 inhibits the migration and invasion of non-small-cell lung cancer cells in vivo and in vitro

Lou, Rui, Cao, Haixia, Dong, Shuchen, Shi, Chen, Xu, Xiaoyue, Ma, Rong, Wu, Jianzhong, Feng, Jifeng

Journal:

Anti-Cancer Drugs

Year:

2019

File:

PDF, 267 KB

2019

9

Case series of MET exon 14 skipping mutation-positive non-small-cell lung cancers with response to crizotinib and cabozantinib

Wang, Samantha X.Y., Zhang, Bing M., Wakelee, Heather A., Koontz, Michael Z., Pan, MingGui, Diehn, Maximilian, Kunder, Christian A., Neal, Joel W.

Journal:

Anti-Cancer Drugs

Year:

2019

File:

PDF, 147 KB

2019

10

Preparation of truncated tissue factor antineuropilin-1 monoclonal antibody conjugate and identification of its selective thrombosis in tumor blood vessels

Xu, Peilan, Zou, Mingyuan, Wang, Shengyu, Wang, Li, Wang, Lanlan, Luo, Fanghong, Wu, Ting, Yan, Jianghua

Journal:

Anti-Cancer Drugs

Year:

2019

File:

PDF, 487 KB

2019

11

Temozolomide cytoreductive treatment in a giant cabergoline-resistant prolactin-secreting pituitary neuroendocrine tumor

Ceccato, Filippo, Lombardi, Giuseppe, Albiger, Nora, Mazzai, Linda, Pambuku, Ardi, Rolma, Giuseppe, Zagonel, Vittorina, Scaroni, Carla

Journal:

Anti-Cancer Drugs

Year:

2019

File:

PDF, 136 KB

2019